Tuesday, September 22, 2020
wellness India Expo
Home Tags Biopharma

Tag: biopharma

DBT seed funds Gennova’s novel mRNA based COVID-19 vaccine, HGCO19

Vaccine Discovery Programme supported by the Department of Biotechnology, Govt. of India under Ind CEPI, implemented by BIRAC will soon move into clinical trials...............

India launches ‘Drug Discovery Hackathon 2020’ to accelerate drug discovery process

While the union S&T minister, Dr Harsh Vardhan stated that in-silico drug discovery which utilizes computational methods such as Machine Learning, AI (Artificial Intelligence) and Big Data will help in accelerating this process.................

Workflow optimization is a key priority for Indian pharma labs, reveals...

Instrumentation with improved reliability and accuracy will be key to facilitating higher productivity, revealed the survey where respondents included 650 laboratory managers, directors, and supervisors from China, Germany, India, South Korea, Switzerland, Austria, and the United States.......................

World Hemophilia Day: Takeda India stands united for hemophilia patients

While approximately 21,000 hemophilic patients are registered in India, the ongoing government support, standards of care have improved in the country......................

Agilent improves bioanalytical workflow solutions

Updated system meets challenges of India’s changing lab landscape................

Takeda appoints Dr Mahender Nayak as new Area Head for India

Proven leader with more than 20 years of experience in the biopharmaceutical industry, Dr Mahender Nayak will continue to increase patient access to Takeda’s portfolio of highly innovative medicines..................

#BioAsia2020: India’s Pharma & Biotech Industry aims $100 billion through innovations

Speaking on the 2nd day of BioAsia 2020, Union Minister Mr Piyush Goyal said that the patent applications will be approved in record time to enable the industry to discover innovative drugs..................

ICT-Mumbai to organize ‘Biosimilar Workshop 2020’ in February

Institute of Chemical Technology (ICT), Mumbai, is conducting the 3rd Biosimilar Workshop from February 3-8, 2020. Participants will also have the opportunity to hear from leaders of the Indian and global biopharma industry, providing a perspective on the training programs...............

Novartis’s 5 year long clinical study on type 2 diabetes treatment...

Early combination treatment strategy with vildagliptin and metformin was superior to the standard of care in newly diagnosed type 2 diabetes patients. The landmark VERIFY study is the first to investigate the long-term clinical benefits of this early combination strategy in type 2 diabetes...................

Sun Pharma makes an entry into generic pharma market in Mainland...

Sun Pharma and China Medical System Holdings have entered into licensing agreement for generic products in Mainland China..............